Bildnachweis: Pixabay, VC Magazin.
In the newest Impact Life Sciences Special, we explore current technology trends – this time with a focus on medical technology. Industry experts provide insights into how the field is influenced by geopolitics, the regulatory challenges facing founders and investors, and the key factors behind successful medtech M&A transactions.
Founders in the fields of diagnostics, digital health and laboratory equipment currently have particularly strong prospects for securing investment. The reasons behind this trend are
explored in our market overview. In our cover interview, we spoke with Dr Philipp Baaske, founder of NanoTemper Technologies, who was recently appointed Vice President of Ludwig Maximilian University of Munich (LMU). In taking up his new role, he is stepping back from the operational management of his start-up. He spoke to us about his plans and his new book – including some valuable advice for aspiring founders.
Start-ups in the life sciences sector still face considerable challenges when seeking capital. In addition to funding, there is often a lack of confidence to reach out to leading industry players, establish networks, and connect with customers, users, and clinicians. It takes more than innovation to transform academic research into a viable, scalable business model – and perhaps even to build a stock market success story like Ottobock. In two engaging founder interviews with Aatec and Ebenbuild, the respective CEOs share how they managed the translation from research to market readiness and overcame the many challenges along the way. Finally, our case study on CorTec highlights a pioneering company in the field of brain-computer interfaces, showcasing a significant milestone in neurotechnology.
